Break Free the Bonds of COPD
D’OXYVA® enhances the rest and digest (parasympathetic) nerve activation process in the part of the brain that is responsible for all subconscious functions (ANS) and microcirculation processes to invigorate your lung capacity.
Join our newsletter today and get the first dibs to new articles and exclusive discounts!
invigorate your lung capacity
enhance Essential Nerve Activities and microcirculation processes
According to a study published in Archives of Medical Science, patients with COPD, decreased systemic oxygen levels lead to endothelial dysfunction, underlining the relevance of cardiopulmonary interaction and the potential importance of pulmonary treatment in secondary prevention of vascular disease.
D’OXYVA® (deoxyhemoglobin vasodilator) is the pioneering non-invasive biotech solution created by the health science experts at Circularity — validated to signigicantly increase microcirculation and oxygentaion in a single painless, convenient, and affordable solution.
versatile, non-toxic
D’OXYVA for Advanced Neonatal Care
As part of a carefully planned application protocol for newborn infants in neonatal care and neonatal ICU facilities, D’OXYVA’s versatile, over-the-skin, non-toxic CO₂ and soothing vapor delivery system has the potential to dramatically improve microcirculation and the comprehensive function of developing lungs.
NON-TOXIC
NON-OPIOID
PAIN-FREE
WASTE-FREE
act now before it's too late
What Makes D’OXYVA Truly Different
Many treatments make bold online claims to help cure various conditions and restore you to health -- pills, shots, creams, procedures, and devices.
But only science-backed, one-of-a-kind D’OXYVA stands alone, delivering the remarkable physical, mental, and emotionally rejuvenating results that traditional medicine -- and our countless imitators -- simply cannot provide.
The wholly unique D’OXYVA biotech solution harnesses the proven power of microcirculation to stimulate your body’s natural injury-healing, infection-fighting, energy-enhancing processes exponentially; and, it does so in a non-toxic, painless, 5-minute handheld delivery application in the comfort and privacy of your own home.
Recent Related Blog Posts
Looking into the eye of patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a complex disease with many patients suffering from cardiovascular comorbidity. However, cardiovascular diseases remain often undiagnosed in COPD. Share it: Share on facebook Share
Impaired Hemorheology in Exacerbations of COPD
Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation. Cardiovascular-related comorbidities are established to contribute to morbidity and mortality especially during exacerbations. The aim of the current study
The Epidemiology of Vascular Dysfunction Relating to Chronic Obstructive Pulmonary Disease and Emphysema
Cor pulmonale has long been described in very severe chronic obstructive pulmonary disease (COPD) and emphysema. Cross-sectional results from population-based studies show that left ventricular filling and a variety of
Reduce unwanted doctor visits, recommended and ranked top by experts!
